These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 24969090)

  • 21. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
    Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
    Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptide YY levels are elevated after gastric bypass surgery.
    Chan JL; Mun EC; Stoyneva V; Mantzoros CS; Goldfine AB
    Obesity (Silver Spring); 2006 Feb; 14(2):194-8. PubMed ID: 16571843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery.
    Werling M; Vincent RP; Cross GF; Marschall HU; Fändriks L; Lönroth H; Taylor DR; Alaghband-Zadeh J; Olbers T; Le Roux CW
    Scand J Gastroenterol; 2013 Nov; 48(11):1257-64. PubMed ID: 24044585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.
    le Roux CW; Welbourn R; Werling M; Osborne A; Kokkinos A; Laurenius A; Lönroth H; Fändriks L; Ghatei MA; Bloom SR; Olbers T
    Ann Surg; 2007 Nov; 246(5):780-5. PubMed ID: 17968169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.
    le Roux CW; Aylwin SJ; Batterham RL; Borg CM; Coyle F; Prasad V; Shurey S; Ghatei MA; Patel AG; Bloom SR
    Ann Surg; 2006 Jan; 243(1):108-14. PubMed ID: 16371744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass.
    Stoeckli R; Chanda R; Langer I; Keller U
    Obes Res; 2004 Feb; 12(2):346-50. PubMed ID: 14981228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distal small bowel bypass for weight regain after gastric bypass: safety and efficacy threshold occurs at <70% bypass.
    Caruana JA; Monte SV; Jacobs DM; Voytovich C; Ghanim H; Dandona P
    Surg Obes Relat Dis; 2015; 11(6):1248-55. PubMed ID: 26499355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review.
    Beckman LM; Beckman TR; Earthman CP
    J Am Diet Assoc; 2010 Apr; 110(4):571-84. PubMed ID: 20338283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of beta-cell function for improved glycemic control after gastric bypass surgery.
    Blanco J; Jiménez A; Casamitjana R; Flores L; Lacy A; Conget I; Vidal J
    Surg Obes Relat Dis; 2014; 10(1):9-13; quiz 189-90. PubMed ID: 24342036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels.
    Korner J; Inabnet W; Conwell IM; Taveras C; Daud A; Olivero-Rivera L; Restuccia NL; Bessler M
    Obesity (Silver Spring); 2006 Sep; 14(9):1553-61. PubMed ID: 17030966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes.
    Rhee NA; Wahlgren CD; Pedersen J; Mortensen B; Langholz E; Wandall EP; Friis SU; Vilmann P; Paulsen SJ; Kristiansen VB; Jelsing J; Dalbøge LS; Poulsen SS; Holst JJ; Vilsbøll T; Knop FK
    Diabetologia; 2015 Oct; 58(10):2254-8. PubMed ID: 26186884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Similar Gut Hormone Secretions Two Years After One Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass: a Pilot Study.
    De Bandt D; Rives-Lange C; Frigout Y; Bergerot D; Blanchard A; Le Gall M; Lacorte JM; Chevallier JM; Czernichow S; Poghosyan T; Carette C; Le Beyec J
    Obes Surg; 2022 Mar; 32(3):757-762. PubMed ID: 34993850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial.
    Peterli R; Wölnerhanssen B; Peters T; Devaux N; Kern B; Christoffel-Courtin C; Drewe J; von Flüe M; Beglinger C
    Ann Surg; 2009 Aug; 250(2):234-41. PubMed ID: 19638921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responses of gut and pancreatic hormones, bile acids, and fibroblast growth factor-21 differ to glucose, protein, and fat ingestion after gastric bypass surgery.
    Jensen CZ; Bojsen-Møller KN; Svane MS; Holst LM; Hermansen K; Hartmann B; Wewer Albrechtsen NJ; Kuhre RE; Kristiansen VB; Rehfeld JF; Clausen TR; Holst JJ; Madsbad S
    Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G661-G672. PubMed ID: 32068442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release.
    Rodieux F; Giusti V; D'Alessio DA; Suter M; Tappy L
    Obesity (Silver Spring); 2008 Feb; 16(2):298-305. PubMed ID: 18239636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term results of a randomized clinical trial comparing Roux-en-Y gastric bypass with vertical banded gastroplasty.
    Werling M; Fändriks L; Björklund P; Maleckas A; Brandberg J; Lönroth H; le Roux CW; Olbers T
    Br J Surg; 2013 Jan; 100(2):222-30. PubMed ID: 23180572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss.
    Reinehr T; Roth CL; Schernthaner GH; Kopp HP; Kriwanek S; Schernthaner G
    Obes Surg; 2007 Dec; 17(12):1571-7. PubMed ID: 18046613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass.
    Korner J; Inabnet W; Febres G; Conwell IM; McMahon DJ; Salas R; Taveras C; Schrope B; Bessler M
    Int J Obes (Lond); 2009 Jul; 33(7):786-95. PubMed ID: 19417773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Impacts of laparoscopic bariatric surgery on GLP-1 and Ghrelin level in patients with type 2 diabetes mellitus].
    Guo X; Yin K; Chen DL; Chang XS; Zeng P; Zheng CZ
    Zhonghua Wai Ke Za Zhi; 2013 Apr; 51(4):323-7. PubMed ID: 23895753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ghrelin and peptide YY levels after a variant of biliopancreatic diversion with Roux-en-Y gastric bypass versus after colectomy: a prospective comparative study.
    Stratis C; Alexandrides T; Vagenas K; Kalfarentzos F
    Obes Surg; 2006 Jun; 16(6):752-8. PubMed ID: 16756737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.